As the cost to bring new therapeutics to the market continues to soar, it is more important than ever for Life Sciences companies to develop robust Market Access strategies. Mindy & Ryan are joined by Vynamic’s Raina Dhir and Maggie Gorman to discuss the criticality of Market Access in ensuring successful drug launches and how Life Sciences organizations can ensure they avoid pitfalls and are set up for success. There are many forces disrupting the Life Sciences marketplace that have led to increased complexities around bringing new drugs to market. Payors and Pharmaceutical Benefit Managers have undergone a period of marketplace consolidation, changing the structure of payments and formulary negotiations. We’ve also seen the emergence of larger ‘payviders’ – or integrated provider and payor groups – where the stakeholder is uniformly focused on cost-effectiveness. These payviders have rolled out prohibitive utilization management programs to curb spending on new therapeutics. Compounding this scrutiny on pricing is the increasing cost of specialty drugs as well as cell- and gene-therapies. All these factors clearly spell out the need for Life Sciences organizations to put a greater emphasis on the Market Access function (04:30). Planning needs to happen early and teams need to form robust yet agile strategic approaches to navigate the ever-shifting landscape (12:43). Most critically, the Market Access function needs to have cross-functional visibility and authority to help guide the strategic direction of new product launches (16:41).
Podcast Tags: healthcare, market access, product launch, life sciences, pharmaceuticals, biotech, payors, providers, utilization management, cost-effectiveness
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Raina Dhir, Vynamic Director
Maggie Gorman, Vynamic Manager
Mindy McGrath, Healthcare Industry Advisor
Ryan Hummel, Executive and Head of Provider Sector
About Vynamic
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Want to learn more? Get in touch!
Related Podcasts:
Felice Walter
Rethinking Launch Planning: Investing Early for Launch Success
Life science organizations often encounter challenges with aligning strategy and execution during a product launch, leading to inefficiencies...
Read more
Felice Walter
Embedding launch excellence as a cultural mindset: Going beyond frameworks, playbooks, and functional checklists to empower teams to focus on what matters most
In today's competitive pharmaceutical environment, the success of product launches hinges on the ability to prioritize outcomes over rigid processes..
Read moreAccounts, Collaboration & Pragmatism: Reuters Pharma Customer Engagement Round-Up
Last month, Life Sciences marketing, commercial and medical leaders from across the country gathered at Reuter’s...
Listen now